Printer Friendly

Articles from M2 Pharma (February 1, 2019)

1-24 out of 24 article(s)
Title Author Type Words
Alexion, Caelum Biosciences Team to Develop Targeted Therapy for Light Chain Amyloidosis. 746
Altamont Capital Partners acquires Publicis Healthcare Solutions. 140
Altamont Capital Partners closes acquisition of Publicis Healthcare Solutions. 202
Co-Diagnostics to Raise USD 5.5m from Registered Direct Offering. 339
Eli Lilly wins US FDA's approval for new indication of ALIMTA (pemetrexed for injection) and KEYTRUDA (pembrolizumab) combination for NSCLC. 317
Hansa Medical reports on conversion of shares. 140
Immunicum reports on changes in number of shares and votes due to rights issue. 139
Innovus Pharma Launches OTC Hemorrhoid Xyralid Suppositories in Canada. 355
IntoCell reports publication of the patent application for OHPAS linker technology for antibody drug conjugates in Korea. 189
Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children. 391
KalVista Pharmaceuticals Names Pereira to Board of Directors. 353
LLC's MedBank Medical Solutions expands collaboration with Phoebe Pharmacy. 116
Medliminal Names New Board of Directors for 2019. 334
Mylan wins US FDA approval for Wixela Inhub for treating asthma & COPD patients. 265
Navidea Biopharmaceuticals' NYSE American Listing Extended. 382
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy. 558
Prana Receives First Orphan Drug Designation from the FDA for the Treatment of Multiple System Atrophy. 238
Pulmatrix Inc concludes USD265,400 public offering. 124
REGENXBIO wins US FDA's Rare Pediatric Disease Designation for RGX-181 Gene Therapy for the CLN2 Batten Disease. 226
Swedish Orphan Biovitrum's number of shares and votes increase in connection with acquisition of US right to Synagis. 147
Teva Receives Positive Committee for Medicinal Products for Human Use Opinion for Ajovy for the Prophylaxis of Migraine in Adults. 363
Titan Pharmaceuticals Inc relaunches Probuphine (buprenorphine) implant for the US Opioid Use Disorder market. 270
USFDA approves Eureka Therapeutics investigational new drug for ET140202 ARTEMIS T-cell therapy. 153
USFDA grants breakthrough therapy designation to Merck vaccine. Clinical report 176

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |